Open access
Open access
Powered by Google Translator Translator

Daily Archives: August 3, 2022

Guideline | Preventing obesity in midlife women.

3 Aug, 2022 | 14:37h | UTC

Preventing Obesity in Midlife Women: A Recommendation From the Women’s Preventive Services Initiative – Annals of Internal Medicine

News Release: Women’s Preventive Services Initiative issues guidelines for preventing obesity in midlife women – American College of Physicians

Commentary: Counseling Can Prevent Obesity in Normal, Overweight Women – HealthDay

 

Commentary on Twitter

 

M-A | Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials.

3 Aug, 2022 | 14:31h | UTC

Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis – The BMJ

 

RECOVERY Trial | Baricitinib in patients admitted to hospital with COVID-19.

3 Aug, 2022 | 14:34h | UTC

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – The Lancet

Invited Commentary: Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality – The Lancet

Related:

Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial – medRxiv

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial – The Lancet Respiratory Medicine

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis – medRxiv

WHO recommends two new drugs to treat COVID-19 – World Health Organization

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial – The Lancet Respiratory Medicine

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19 – New England Journal of Medicine

 

Commentary on Twitter

Under a Creative Commons Attribution (CC BY 4.0) license

 

Antivirals with activity against Monkeypox: a clinically oriented review.

3 Aug, 2022 | 14:26h | UTC

Antivirals with Activity Against Monkeypox: A Clinically Oriented Review – Clinical Infectious Diseases

Related:

WHO chief advises men who have sex with men to reduce partners to limit exposure to monkeypox – CNN

Clinical features and novel presentations of human monkeypox in a central London centre during the 2022 outbreak: descriptive case series – The BMJ

WHO Declares Global Public Health Emergency Over Monkeypox Virus Outbreak – Health Policy Watch

Monkeypox Virus Infection in Humans across 16 Countries — April–June 2022 – New England Journal of Medicine

Monkeypox: A Contemporary Review for Healthcare Professionals – Open Forum Infectious Diseases

 

Review | Diagnosis, treatment, and prevention of Malaria in the US.

3 Aug, 2022 | 14:27h | UTC

Diagnosis, Treatment, and Prevention of Malaria in the US: A Review – JAMA (free for a limited period)

Audio Clinical Review: Diagnosis, Treatment, and Prevention of Malaria in the US – JAMA

 

Cohort Study | Association between gout flare and subsequent cardiovascular events among patients with gout.

3 Aug, 2022 | 14:30h | UTC

Association Between Gout Flare and Subsequent Cardiovascular Events Among Patients With Gout – JAMA (free for a limited period)

Editorial: Cardiovascular Events and Gout Flares – JAMA (free for a limited period)

News Release: Flare-ups of gout are linked to heart attack and stroke – University of Nottingham

Commentary: Association Between Gout Flare and Subsequent Cardiovascular Events – American College of Cardiology

 

Cohort Study | Association of higher-dose fluoroquinolone therapy with serious adverse events in older adults with advanced chronic kidney disease.

3 Aug, 2022 | 14:22h | UTC

Association of Higher-Dose Fluoroquinolone Therapy With Serious Adverse Events in Older Adults With Advanced Chronic Kidney Disease – JAMA Network Open

 

Evidence Synthesis | Deprescribing medicines in older people living with multimorbidity and polypharmacy.

3 Aug, 2022 | 14:20h | UTC

Deprescribing medicines in older people living with multimorbidity and polypharmacy: the TAILOR evidence synthesis – Health Technology Assessment

Related:

Antihypertensive Deprescribing in Older Adults: a Practical Guide – Current Hypertension Reports

How-to guide for medication reviews in older adults with cancer: A Young International Society of Geriatric Oncology and Nursing & Allied Health Interest Group initiative – Journal of Geriatric Oncology

Deprescribing in Palliative Cancer Care – Life

Less is More: Deprescribing Medications in Older Adults with Kidney Disease: A Review – Kidney360

Process evaluation of implementation strategies to reduce potentially inappropriate medication prescribing in older population: A scoping review – Research in Social and Administrative Pharmacy

AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review – Gastroenterology

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults – JAMA Network Open

The MedSafer Study—Electronic Decision Support for Deprescribing in Hospitalized Older Adults: A Cluster Randomized Clinical Trial – JAMA Internal Medicine

Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models – Drugs & Aging

Deprescribing in palliative patients with cancer: a concise review of tools and guidelines – Supportive Care in Cancer

Prescribing practices, patterns, and potential harms in patients receiving palliative care: A systematic scoping review – Exploratory Research in Clinical and Social Pharmacy

A narrative review of evidence to guide deprescribing among older adults – Journal of General and Family Medicine

Polypharmacy, inappropriate prescribing, and deprescribing in older people: through a sex and gender lens – The Lancet Health Longevity

Polypharmacy Management in Older Patients – Mayo Clinic Proceedings

Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy – Deutsches Ärzteblatt international

Eliminating Medication Overload: A National Action Plan – Lown Institute

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action – Drugs & Aging

Common ED Medication Errors: Polypharmacy – emDocs

Current and future perspectives on the management of polypharmacy – BMC Family Practice

Routine deprescribing of chronic medications to combat polypharmacy – Therapeutic Advances in Drug Safety

Polypharmacy—an Upward Trend with Unpredictable Effects – Deutsches Ärzteblatt international

Clinical Consequences of Polypharmacy in Elderly – Expert Opinion on Drug Safety

 

Designing Infographics | Visual representations for enhancing education, communication, and scientific research.

3 Aug, 2022 | 14:24h | UTC

Designing Infographics: Visual Representations for Enhancing Education, Communication, and Scientific Research – Journal of Korean Medical Science

Related:

Creating Effective Infographics and Visual Abstracts to Disseminate Research and Facilitate Medical Education on Social Media

As scientists take to Twitter, study shows power of ‘visual abstract’ graphics – Scienmag

See also: an open-source primer on visual abstracts

 

Deep learning electrocardiographic analysis for detection of left-sided valvular heart disease.

3 Aug, 2022 | 14:19h | UTC

Deep Learning Electrocardiographic Analysis for Detection of Left-Sided Valvular Heart Disease – Journal of the American College of Cardiology

 

Commentary from the author on Twitter (thread – click for more)

 

Guideline | Male lower urinary tract symptoms/benign prostatic hyperplasia.

3 Aug, 2022 | 14:17h | UTC

UPDATE – 2022 Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH) – Canadian Urological Association Journal

Related:

AUA Guidelines: Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.

Podcast: LUTS, BPH, and Urinary Incontinence Triple Distilled – The Curbsiders

Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia – Cochrane Library

Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta‐analysis – Cochrane Library

Phosphodiesterase inhibitors for treatment of urinary problems in men with benign prostatic hyperplasia – Cochrane Library

Thulium laser transurethral vaporesection of the prostate versus transurethral resection of the prostate for men with lower urinary tract symptoms or urinary retention (UNBLOCS): a randomised controlled trial – The Lancet

 

Guideline | Androgen deprivation therapy: adverse events and management strategies.

3 Aug, 2022 | 14:15h | UTC

UPDATE – Canadian Urological Association guideline on androgen deprivation therapy: Adverse events and management strategies (Full-text) – Canadian Urological Association Journal

 

RCT | Effect of graded sensorimotor retraining on pain intensity in patients with chronic low back pain.

3 Aug, 2022 | 14:08h | UTC

Effect of Graded Sensorimotor Retraining on Pain Intensity in Patients With Chronic Low Back Pain: A Randomized Clinical Trial – JAMA (free for a limited period)

News release: An effective new treatment for chronic back pain targets the nervous system – University of New South Wales

 

Commentary on Twitter

 

Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis.

3 Aug, 2022 | 14:09h | UTC

Consensus statements for pharmacological management, monitoring of therapies, and comorbidity management of psoriatic arthritis in the United Arab Emirates – International Journal of Rheumatic Diseases

 

RCT | Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction.

3 Aug, 2022 | 14:06h | UTC

Patiromer for the management of hyperkalemia in heart failure with reduced ejection fraction: the DIAMOND trial – European Society of Cardiology

 

Commentary on Twitter

 

M-A | Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021.

3 Aug, 2022 | 14:04h | UTC

Global prevalence of non-tuberculous mycobacteria in adults with non-cystic fibrosis bronchiectasis 2006–2021: a systematic review and meta-analysis – BMJ Open

 

Study shows the incidence of obesity among US children is increasing.

3 Aug, 2022 | 14:00h | UTC

Changes in the Incidence of Childhood Obesity – Pediatrics

Original Study: Childhood Obesity Rate in the U.S. Higher Now Than 12 Years Prior – HealthDay

 

RCT | Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy.

3 Aug, 2022 | 14:02h | UTC

Sintilimab plus bevacizumab biosimilar IBI305 and chemotherapy for patients with EGFR-mutated non-squamous non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitor therapy (ORIENT-31): first interim results from a randomised, double-blind, multicentre, phase 3 trial – The Lancet Oncology (link to abstract – $ for full-text)

 

Commentary on Twitter

 

Review | Management of alcohol-related liver disease and its complications.

3 Aug, 2022 | 13:56h | UTC

Management of Alcohol-Related Liver Disease and Its Complications – Clinical Drug Investigation

Related Guideline: Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines – Liver International

 

Commentary on Twitter (thread – click for more)

 

Cohort Study | Association between early left ventricular ejection fraction improvement after transcatheter aortic valve replacement and 5-year clinical outcomes.

3 Aug, 2022 | 13:58h | UTC

Association Between Early Left Ventricular Ejection Fraction Improvement After Transcatheter Aortic Valve Replacement and 5-Year Clinical Outcomes – JAMA Cardiology (link to abstract – $ for full-text)

Commentary: Early LV Recovery After TAVI Points to Better 5-Year Survival – TCTMD

 

Commentary on Twitter

 

Trends in thoracic aortic aneurysm hospital admissions, interventions and mortality in England between 1998 to 2020: An observational study.

3 Aug, 2022 | 13:55h | UTC

Trends in thoracic aortic aneurysm hospital admissions, interventions and mortality in England between 1998 to 2020: An observational study – European Journal of Vascular & Endovascular Surgery

 

Cohort Study | Incidence of acute chest syndrome in children with sickle cell disease following implementation of the 13-valent pneumococcal conjugate vaccine.

3 Aug, 2022 | 13:53h | UTC

Incidence of Acute Chest Syndrome in Children With Sickle Cell Disease Following Implementation of the 13-Valent Pneumococcal Conjugate Vaccine in France – JAMA Network Open

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.